4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-059637
Chief Financial Officer acquired 68,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fenton Mary Kay · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-18 | Grant or award : show line 1 in the form | +68,750 | 130,778 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-18 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +137,500 | 137,500 | D |
Loading xslF345X05/ownership.xml…